VRTX
$499.74-1.77%
as of close, Oct 16, 2026
☾ AH $499.74 -1.77%
Vertex Pharmaceuticals IncorporatedStock · HealthcareNasdaq-100 0.5%Nasdaq Composite 0.2%S&P 500 Equal Weight 0.2%S&P 500 0.2%Russell 1000 0.2%Russell 3000 0.2%US Stock Market 0.2%MSCI World 0.1%MSCI ACWI 0.1%
Vertex Pharmaceuticals Incorporated total returns by year (including dividends)
As of market close, Oct 16, 2026
Vertex Pharmaceuticals Incorporated total returns by year (1992–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $453.36 | $499.74 | 0.0% | +10.2% | |
| 2025 | $402.70 | $453.36 | 0.0% | +12.6% | |
| 2024 | $406.89 | $402.70 | 0.0% | -1.0% | |
| 2023 | $288.78 | $406.89 | 0.0% | +40.9% | |
| 2022 | $219.60 | $288.78 | 0.0% | +31.5% | |
| 2021 | $236.34 | $219.60 | 0.0% | -7.1% | |
| 2020 | $218.95 | $236.34 | 0.0% | +7.9% | |
| 2019 | $165.71 | $218.95 | 0.0% | +32.1% | |
| 2018 | $149.86 | $165.71 | 0.0% | +10.6% | |
| 2017 | $73.67 | $149.86 | 0.0% | +103.4% | |
| 2016 | $125.83 | $73.67 | 0.0% | -41.5% | |
| 2015 | $118.80 | $125.83 | 0.0% | +5.9% | |
| 2014 | $74.30 | $118.80 | 0.0% | +59.9% | |
| 2013 | $41.90 | $74.30 | 0.0% | +77.3% | |
| 2012 | $33.21 | $41.90 | 0.0% | +26.2% | |
| 2011 | $35.03 | $33.21 | 0.0% | -5.2% | |
| 2010 | $42.85 | $35.03 | 0.0% | -18.2% | |
| 2009 | $30.38 | $42.85 | 0.0% | +41.0% | |
| 2008 | $23.23 | $30.38 | 0.0% | +30.8% | |
| 2007 | $37.42 | $23.23 | 0.0% | -37.9% | |
| 2006 | $27.67 | $37.42 | 0.0% | +35.2% | |
| 2005 | $10.57 | $27.67 | 0.0% | +161.8% | |
| 2004 | $10.35 | $10.57 | 0.0% | +2.1% | |
| 2003 | $15.85 | $10.35 | 0.0% | -34.7% | |
| 2002 | $24.59 | $15.85 | 0.0% | -35.5% | |
| 2001 | $71.50 | $24.59 | 0.0% | -65.6% | |
| 2000 | $17.50 | $71.50 | 0.0% | +308.6% | |
| 1999 | $14.88 | $17.50 | 0.0% | +17.6% | |
| 1998 | $16.50 | $14.88 | 0.0% | -9.8% | |
| 1997 | $20.13 | $16.50 | 0.0% | -18.0% | |
| 1996 | $13.25 | $20.13 | 0.0% | +51.9% | |
| 1995 | $7.50 | $13.25 | 0.0% | +76.7% | |
| 1994 | $9.25 | $7.50 | 0.0% | -18.9% | |
| 1993 | $4.88 | $9.25 | 0.0% | +89.7% | |
| 1992 | $7.38 | $4.88 | 0.0% | -33.9% |
- Annualized
- +14.3%
- 1992–2026
- Average year
- +26.4%
- 34 full years
- Best year
- +308.6%
- 2000
- Worst year
- -65.6%
- 2001
- Positive years
- 21/34
- 62% up
Annualized (CAGR)
+14.3%
1992–2026
Average year
+26.4%
34 full years
Best year
+308.6%
2000
Worst year
-65.6%
2001
Positive years
21/34
62% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
1992-34%'92
1993+90%
1994-19%
1995+77%'95
1996+52%
1997-18%
1998-9.8%'98
1999+18%
2000+309%
2001-66%'01
2002-36%
2003-35%
2004+2.1%'04
2005+162%
2006+35%
2007-38%'07
2008+31%
2009+41%
2010-18%'10
2011-5.2%
2012+26%
2013+77%'13
2014+60%
2015+5.9%
2016-41%'16
2017+103%
2018+11%
2019+32%'19
2020+7.9%
2021-7.1%
2022+32%'22
2023+41%
2024-1.0%
2025+13%'25
2026+10%
Methodology#
Total returns, dividends reinvested, measured on VRTX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Vertex Pharmaceuticals Incorporated's average annual return?
- Since 1992, Vertex Pharmaceuticals Incorporated (VRTX) has returned about 14.3% a year (the compound annual growth rate) and an average calendar-year return of 26.4%.
- What were Vertex Pharmaceuticals Incorporated's best and worst years?
- Over 1992–2026, the best year was 2000 (+308.6%) and the worst was 2001 (-65.6%).
- How often is Vertex Pharmaceuticals Incorporated up in a year?
- 21 of the 34 full years since 1992 were positive — about 62% of the time.
More on Vertex Pharmaceuticals Incorporated
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100